Results 101 to 110 of about 27,602 (209)

Effectiveness of enoxaparin in preventing intraoperative fibrin formation during DMEK assessed in a before-and-after study

Scientific Reports
To demonstrate that enoxaparin in the irrigation saline solution can effectively prevent intraoperative fibrin formation (IFF) during Descemet membrane endothelial keratoplasty (DMEK) surgery without compromising graft viability, visual recovery, or ...
Pablo De-Arriba-Palomero, David Mingo-Botín, Jaime Etxebarría-Ecenarro, Javier Celis, María Teresa Merino-Diez, Cristina García-Tomás, Martha Stokking, Juan Álvarez de Toledo, Francisco J. Muñoz-Negrete, Francisco Arnalich-Montiel   +9 more
doaj   +1 more source

Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis

Journal of Nanotechnology, 2017
This study was based on the preparation, characterization, and animal in vivo experiments performed to evaluate nanoparticles of poly(ɛ-caprolactone) (PCL) and chitosan as carriers of enoxaparin.
Lucas Bessa Prado, Stephany Cares Huber, Aline Barnabé, Fernanda Dutra Santiago Bassora, Devanira Souza Paixão, Nelson Duran, Joyce Maria Annichino-Bizzacchi   +6 more
doaj   +1 more source

The Efficacy of Low-Dose Enoxaparin in Psoriasis

, 2022
Psoriasis is a frequently encountered inflammatory skin disease with unclear etiology and no curative therapy. Enoxaparin is a low-molecular weight heparin analogue.
Atakan, Nilgün, Demircioğlu, Deniz
core  

Apixaban versus enoxaparin in patients with total knee arthroplasty

, 2011
SummaryIt was the objective of this study to systematically compare the effects of apixaban versus enoxaparin in patients following total knee arthroplasty (TKA).
Liucheng Wu, Yunfei Cao, Jiahao Huang, Feng Gao, Cun Liao   +4 more
core   +1 more source

Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study

Journal of Research in Pharmacy Practice
Objective: Anticoagulation therapy, including enoxaparin, is crucial for preventing blood clots in patients at risk for thromboembolic events. However, due to enoxaparin’s enhanced renal elimination, proper prophylactic dosing may be challenging.
Zahra Sahraei, Azadeh Eshraghi, Saghar Barati   +2 more
doaj   +1 more source

A Case of an Allergic Contact Dermatitis Following the Administration of Enoxaparin: A Case Report and Review of the Literature. [PDF]

Clin Med Insights Case Rep
Introduction: Allergic contact dermatitis (ACD) is a rare but clinically significant hypersensitivity reaction to certain medications, including enoxaparin, a commonly used low-molecular-weight heparin (LMWH) for venous thromboembolism (VTE) prophylaxis.
Alotaibi HM, Alajlan A, Alluhaybi A, Alhumidi AA.   +3 more
europepmc   +2 more sources

Effect of enoxaparin on macrophage infiltration into the inflamed colon.

, 2015
(A) Representative immunostaining of F4/80-positive macrophages in in the distal colon from healthy and colitic mice treated with and without enoxaparin. (B) Quantification of macrophages (F4/80+ cells) in the colons.
Sarron Randall-Demllo (776243), Rahul P. Patel (698431), Niall Stewart (698428), Sukhwinder Singh Sohal (317561), Nuri Gueven (134653), Rajaraman D. Eri (755888), Qi Ying Lean (755887), Gregory M. Peterson (564167)   +7 more
core   +1 more source

Development of enoxaparin sodium polymeric microparticles for colon-specific delivery

, 2015
International audienceBackground and aimsRecent studies have shown that low molecular weight heparins are effective in the treatment of inflammatory bowel disease.
Ioan Tomuţa, Casteran, Maxime, Hales, Dana, Maincent, Philippe, Achim, Marcela, Laurian Vlase, Anne Sapin-minet, Maxime Casteran, Vlase, Laurian, Tomuţa, Ioan, Marcela Achim, Sapin-Minet, Anne, Philippe Maincent, Dana Hales   +13 more
core   +1 more source

Bioequivalence of a biosimilar enoxaparin sodium to Clexane® after single 100 mg subcutaneous dose: results of a randomized, double-blind, crossover study in healthy volunteers

, 2018
Javier Martínez González, Mayte Monreal, Ignacio Ayani Almagia, Jordi Llaudó Garín, Lourdes Ochoa Díaz de Monasterioguren, Ibón Gutierro Adúriz R&D Department, Laboratorios Farmacéuticos Rovi S.
Ayani Almagia I, Llaudó Garín J, Ochoa Díaz de Monasterioguren L, Martínez González J, Gutierro Adúriz I, Monreal M   +5 more
core  

Use of enoxaparin in end-stage renal disease

, 2013
Enoxaparin has become the treatment of choice for various thromboembolic diseases. In most patients with end-stage renal disease (ESRD), prophylactic dosage of enoxaparin does not appear to be associated with an increased bleeding risk and can be used ...
LAI, SILVIA, Bettina Coppola
core   +1 more source